Physician profile
Keith K Harmon
NPI 1730398165
$9,066.71
in general payments reported to CMS, 2019-2025
38 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $727 · 2020: $7,028 · 2022: $393 · 2023: $582 · 2024: $189 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $903 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $902.97 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,707.28 | 2019-2023 | Da Vinci Surgical System |
| Davol INC. | $174.97 | 2020-2023 | Phasix Mesh |
| Sumitomo Pharma America, INC. | $103.65 | 2023-2024 | Gemtesa |
| Covidien LP | $80.78 | 2019 | |
| 180 Medical, INC. | $75.10 | 2022-2023 | |
| Olympus America INC. | $58.92 | 2023-2025 | Itind System |
| Medtronic, INC. | $57.41 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $54.62 | 2025 | |
| Ethicon US, LLC | $53.82 | 2023-2024 | Enseal |
| Karl Storz Endoscopy-America | $47.66 | 2019 | |
| Smith+Nephew, INC. | $46.34 | 2024-2025 | Renasys Touch, Pico 7, Pico 14 |
| Tela Bio, INC. | $44.14 | 2022 | |
| Braintree Laboratories, INC. | $41.51 | 2022-2024 | Suflave |
| Amgen INC. | $38.41 | 2019 | |
| Merck Sharp & Dohme LLC | $35.48 | 2022 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $28.84 | 2019-2023 | Gattex |
| Janssen Biotech, INC. | $28.22 | 2022-2025 | Erleada |
| Avita Medical Americas, LLC | $26.01 | 2024 | |
| Allergan, INC. | $25.33 | 2019-2022 | |
| Astellas Pharma US INC | $24.72 | 2019 | |
| Ferring Pharmaceuticals INC. | $23.82 | 2025 | Adstiladrin |
| Helsinn Therapeutics (U.S.), INC. | $23.79 | 2019 | |
| Ascensia Diabetes Care US INC. | $23.40 | 2024 | |
| Accord Healthcare, INC. | $22.86 | 2023 | |
| Sun Pharmaceutical Industries INC. | $22.62 | 2022 | |
| Blue Earth Diagnostics | $19.82 | 2019 | |
| Boston Scientific Corporation | $17.58 | 2022 | |
| Endomagnetics LTD | $17.27 | 2022 | |
| Abbvie INC. | $16.74 | 2022 | |
| Shire North American Group INC | $16.19 | 2019 | |
| Ambu INC. | $14.80 | 2022 | |
| Myriad Genetic Laboratories, INC. | $14.49 | 2023 | Prolaris |
| Polynovo North America LLC | $14.08 | 2024 | Novosorb Btm |
| Urovant Sciences INC | $13.94 | 2022 | |
| Kci USA, INC. | $13.73 | 2020 | |
| Incyte Corporation | $13.47 | 2020 | |
| Angiodynamics, INC. | $13.12 | 2024 | Nanoknife |
| Convatec INC. | $11.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.